BR9909346A - Segmento de ácido nucleico, vetor recombinante, célula hospedeira, composição, processos para detectar uma espécie de dna, uma célula bacteriana e infecção, para produzir ácido hialurÈnico e para criar uma vacina, sequência de ácido nucleico e de cdna, vacina e teste diagnóstico - Google Patents

Segmento de ácido nucleico, vetor recombinante, célula hospedeira, composição, processos para detectar uma espécie de dna, uma célula bacteriana e infecção, para produzir ácido hialurÈnico e para criar uma vacina, sequência de ácido nucleico e de cdna, vacina e teste diagnóstico

Info

Publication number
BR9909346A
BR9909346A BR9909346-4A BR9909346A BR9909346A BR 9909346 A BR9909346 A BR 9909346A BR 9909346 A BR9909346 A BR 9909346A BR 9909346 A BR9909346 A BR 9909346A
Authority
BR
Brazil
Prior art keywords
nucleic acid
vaccine
infection
dna
species
Prior art date
Application number
BR9909346-4A
Other languages
English (en)
Inventor
Paul Deangelis
Original Assignee
Univ Oklahoma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Oklahoma filed Critical Univ Oklahoma
Publication of BR9909346A publication Critical patent/BR9909346A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1051Hexosyltransferases (2.4.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

"SEGMENTO DE áCIDO NUCLEICO, VETOR RECOMBINANTE, CéLULA HOSPEDEIRA, COMPOSIçãO, PROCESSOS PARA DETECTAR UMA ESPéCIE DE DNA, UMA CéLULA BACTERIANA E INFECçãO, PARA PRODUZIR áCIDO HIALURÈNICO E PARA CRIAR UMA VACINA, SEQUêNCIA DE áCIDO NUCLEICO E DE CDNA, VACINA E TESTE DIAGNóSTICO". A presente invenção refere-se a segmento de ácido nucleico tendo um segmento de região de codificação codificando hialuronato sintase bacteriana multocida enzimaticamente ativa (PmHAS), e ao uso deste segmento de ácido nucleico na preparação de células recombinantes que produzem hialuronato sintase e seu produto de ácido hialurónico. Hialurónico é também conhecido como ácido hialurónico ou hialuronano. A presente invenção também se refere ao uso de PmHas na construção de cepas mutantes "de abate" de P. multocida para uso em vacinações. A presente invenção ainda se refere ao uso de PmHAS em testes diagnósticos nas determinações de campo de infecção de P. multocida de animais de criação.
BR9909346-4A 1998-04-02 1999-04-01 Segmento de ácido nucleico, vetor recombinante, célula hospedeira, composição, processos para detectar uma espécie de dna, uma célula bacteriana e infecção, para produzir ácido hialurÈnico e para criar uma vacina, sequência de ácido nucleico e de cdna, vacina e teste diagnóstico BR9909346A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8041498P 1998-04-02 1998-04-02
US17885198A 1998-10-26 1998-10-26
PCT/US1999/007289 WO1999051265A1 (en) 1998-04-02 1999-04-01 Nucleic acid encoding hyaluronan synthase and methods of use

Publications (1)

Publication Number Publication Date
BR9909346A true BR9909346A (pt) 2001-09-11

Family

ID=26763480

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9909346-4A BR9909346A (pt) 1998-04-02 1999-04-01 Segmento de ácido nucleico, vetor recombinante, célula hospedeira, composição, processos para detectar uma espécie de dna, uma célula bacteriana e infecção, para produzir ácido hialurÈnico e para criar uma vacina, sequência de ácido nucleico e de cdna, vacina e teste diagnóstico

Country Status (11)

Country Link
EP (2) EP1832662B1 (pt)
JP (2) JP4490581B2 (pt)
CN (2) CN101275143A (pt)
AT (1) ATE501275T1 (pt)
AU (1) AU770903B2 (pt)
BR (1) BR9909346A (pt)
CA (1) CA2326821C (pt)
CZ (1) CZ20003576A3 (pt)
DE (1) DE69943276D1 (pt)
IL (1) IL138803A0 (pt)
WO (1) WO1999051265A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7060469B2 (en) 1998-04-02 2006-06-13 The Board Of Regents Of The University Of Oklahoma Polymer grafting by polysaccharide synthases
IL143080A0 (en) 1998-11-11 2002-04-21 Univ Oklahoma Polymer grafting by polysaccharide synthases
US7534589B2 (en) 1999-11-10 2009-05-19 The Board Of Regents Of The University Of Oklahoma Polymer grafting by polysaccharide synthases
AU4243201A (en) 2000-02-24 2001-09-03 Eidgenoess Tech Hochschule Antibody specific for the ed-b domain of fibronectin, conjugates comprising saidantibody, and their use for the detection and treatment of angiogenesis
DE60139993D1 (de) * 2000-04-25 2009-11-05 Univ Oklahoma Chondroitin synthasegen und verfahren zur dessen herstellung und anwendung
EP1481052B1 (en) * 2001-06-13 2010-06-09 The Board Of Regents Of The University Of Oklahoma Hyaluronan synthase genes and expression thereof
KR100879908B1 (ko) 2001-12-21 2009-01-21 노보자임스 바이오폴리머 에이/에스 재조합체 숙주 세포에서 히알루로난의 제조 방법
JP2009545637A (ja) 2006-08-04 2009-12-24 ノボザイムス バイオファーマ デーコー アクティーゼルスカブ 分岐ヒアルロン酸及びその製造方法
AU2008291695A1 (en) * 2007-08-31 2009-03-05 Sugar Industry Innovation Pty Ltd Production of hyaluronic acid
JP5523338B2 (ja) 2007-12-19 2014-06-18 エヴォニク ゴールドシュミット ゲーエムベーハー エマルジョン中の架橋ヒアルロン酸
CA2732092C (en) * 2008-07-25 2015-02-24 Denki Kagaku Kogyo Kabushiki Kaisha Method for producing hyaluronic acid
CN103562229A (zh) 2011-05-30 2014-02-05 诺维信生物制药丹麦公司 高分子量透明质酸的喷雾干燥
EP2750665A1 (en) 2011-09-02 2014-07-09 Novozymes Biopharma DK A/S Oral formulations containing hyaluronic acid for sustained drug release
CN103255187B (zh) * 2012-02-21 2015-02-18 华熙福瑞达生物医药有限公司 一种低分子透明质酸盐、其制备方法及用途
ITMI20120896A1 (it) 2012-05-23 2013-11-24 Bongulielmi Reto Condroitina per uso in medicina
ITMI20121316A1 (it) 2012-07-27 2014-01-28 Altergon Sa Complessi di condroitina ad assorbimento transcutaneo
WO2014100837A1 (en) 2012-12-17 2014-06-26 Bui The Duy Computer aided implantation of body implants
ES2824402T3 (es) 2013-11-01 2021-05-12 Boehringer Ingelheim Animal Health Usa Inc Vacunas atenuadas contra Pasteurella multocida y procedimientos de fabricación y uso de las mismas
RU2723722C1 (ru) 2019-07-26 2020-06-17 Общество с ограниченной ответственностью "ЦЕНТР ТРАНСФЕРА БИОТЕХНОЛОГИЙ ОКА-Биотех" ТАНДЕМНЫЙ ПРОМОТОР, ФУНКЦИОНИРУЮЩИЙ В БАКТЕРИИ РОДА Bacillus, ТРАНСФОРМИРОВАННАЯ БАКТЕРИЯ РОДА Bacillus - ПРОДУЦЕНТ ЦЕЛЕВОГО ПРОДУКТА, СОДЕРЖАЩАЯ УКАЗАННЫЙ ПРОМОТОР, И СПОСОБ ПОЛУЧЕНИЯ ЦЕЛЕВОГО ПРОДУКТА С ИСПОЛЬЗОВАНИЕМ УКАЗАННОЙ БАКТЕРИИ
RU2719140C1 (ru) 2019-07-26 2020-04-17 Общество с ограниченной ответственностью "ЦЕНТР ТРАНСФЕРА БИОТЕХНОЛОГИЙ ОКА-Биотех" Бактерия рода bacillus, продуцирующая гиалуроновую кислоту, и способ получения гиалуроновой кислоты с использованием указанной бактерии

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6163294A (ja) * 1984-09-05 1986-04-01 Chisso Corp 発酵法によるヒアルロン酸の製造法
US4784990A (en) * 1985-01-18 1988-11-15 Bio-Technology General Corporation High molecular weight sodium hyaluronate
US5015577A (en) * 1989-08-29 1991-05-14 Board Of Regents, The University Of Texas System DNA encoding hyaluronate synthase
CA2061703C (en) * 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
IT1260153B (it) * 1992-06-19 1996-03-28 Michael O'regan Individuazione di un frammento di dna codificante l'enzima acido ialuronico sintetasi (has) e della sua sequenza nucleotidica
US5496726A (en) * 1993-04-16 1996-03-05 Lucky Limited Streptococcus zooepidemicus medium and process for preparing hyaluronic acid
CN1161060A (zh) * 1994-09-12 1997-10-01 M·G·伯杰龙 用于微生物学实验室日常诊断中迅速检测和鉴别临床样品中普通细菌病原体和抗生素抗性基因之特异性和通用性探针及扩增引物
DK0807185T3 (da) * 1995-01-30 2002-10-07 Lunamed Ag Antitumorpræparater indeholdende en lipoteichoinsyre fra streptococcus
WO1997020061A1 (en) * 1995-11-30 1997-06-05 The Scripps Research Institute Synthesis of hyaluronic acid
US6086894A (en) * 1996-06-27 2000-07-11 Virginia Tech Intellectual Properties, Inc. Recombinant vaccine for diseases caused by encapsulated organisms
DE69828193T2 (de) * 1997-10-31 2005-12-01 The Board Of Regents Of The University Of Oklahoma, Norman Hyaluronan synthase gen und seine verwendung
IL143080A0 (en) * 1998-11-11 2002-04-21 Univ Oklahoma Polymer grafting by polysaccharide synthases

Also Published As

Publication number Publication date
EP1832662B1 (en) 2011-03-09
EP1832662A2 (en) 2007-09-12
CN101275143A (zh) 2008-10-01
WO1999051265A1 (en) 1999-10-14
AU770903B2 (en) 2004-03-04
WO1999051265A9 (en) 2000-04-13
IL138803A0 (en) 2001-10-31
AU3548599A (en) 1999-10-25
CN1304317A (zh) 2001-07-18
EP1832662A3 (en) 2007-11-07
CA2326821C (en) 2010-09-28
JP4887333B2 (ja) 2012-02-29
CN1327894C (zh) 2007-07-25
EP1073460A1 (en) 2001-02-07
CZ20003576A3 (cs) 2001-09-12
DE69943276D1 (de) 2011-04-21
JP2008283974A (ja) 2008-11-27
EP1073460A4 (en) 2001-05-23
JP2002510648A (ja) 2002-04-09
CA2326821A1 (en) 1999-10-14
JP4490581B2 (ja) 2010-06-30
ATE501275T1 (de) 2011-03-15

Similar Documents

Publication Publication Date Title
BR9909346A (pt) Segmento de ácido nucleico, vetor recombinante, célula hospedeira, composição, processos para detectar uma espécie de dna, uma célula bacteriana e infecção, para produzir ácido hialurÈnico e para criar uma vacina, sequência de ácido nucleico e de cdna, vacina e teste diagnóstico
DK1025211T3 (da) Hyaluronansyntasegen og anvendelser deraf
DK1011717T3 (da) Arginin-deiminase afledt af mycoplasma-arthritidis og polymere konjugater indeholdende dette
BR0010114A (pt) Vetor biologicamente funcional, molécula de dna, molécula de dna codificada para ribozima, método de clonagem de uma transferase g1cnac-a-1.3-fucosil, método de preparação de células hospedeiras recombinantes, células de plantas recombinantes, insetos ou células de insetos recombinantes, molécula de ácido nucléico de peptìdeo (pna), método de produção de plantas ou insetos ou células, método de produção de glicoproteìnas recombinantes, método de produção de glicoproteìnas humanas, recombinantes, método de produção de gligoproteìnas humanas, recombinantes para uso médico, método de seleção de moléculas de dna codificada para uma transferase g1cnac-a-1,-3-fucosil em uma amostra
BRPI0814781A8 (pt) ''proteína, sequência de ácido nucleico, método para a produção de ácido itacônico, vetor, célula hospedeira, e, uso de um ácido cis-aconítico descarboxilase''
BR9910311A (pt) Moléculas de ácido nucléico codificando enzimas do trigo, que participam da sìntese do amido
BR9911540A (pt) Materiais e métodos para a alteração dos nìveis deenzima e de acetil coa em plantas
BR0003943A (pt) Sequências de nucleotìdeo que codificam para o gene thre e processo para a produção enzimática de l-treonina usando bactérias corineforma
ATE184052T1 (de) Gdf-1 und uog1 proteine
CY1105109T1 (el) Διαδικασια για την παρασκευη μικρου μοριακου βαρους πολυαιθυλενιμινης
BR9910307A (pt) Enzimas de trigo, que codificam moléculas de ácidos nucléicos, que tomam parte na sìntese de amido
WO2000027994A3 (en) Chlamydia pneumoniae genome sequence
DK1100880T3 (da) Urat oxidase
UA118536C2 (uk) Модифікований поліпептид бичачого гранулоцитарного колонієстимулювального фактора та його застосування
WO2000003685A3 (en) Nitrilase homologs
CY1106408T1 (el) Γονιδιωματικη αλληλουχια του χλαμυδιου της πνευμονιας (chlamydia pneymoniae) και πολυπεπτιδια, τμηματα αυτων και χρησεις αυτων, ιδιως για τη διαγνωση, την προληψη και τη θepαπευτικη αντιμετωπιση λοιμωξης
DK1783225T3 (da) Strukturprotein fra AAV, dets fremstilling og anvendelse
CY1109797T1 (el) Μορια πυρηνικου οξεος, κωδικοποιουντα ενζυμα, τα οποια διαθετουν δραστηριοτητα φρουκτοζυλικης τρανσφερασης, και η χρηση αυτων
BR9803960A (pt) Gene de desidrogenase de d-sorbitol.
HK1056748A1 (en) Nucleic acid molecules for detecting bacteria and phylogenetic units of bacteria
BR0112925A (pt) Peptìdeos apresentados por células
BRPI0410562A (pt) molécula recombinante e veìculo para expressão, liberação e purificação de polipeptìdeos alvo
DE69838644D1 (de) Verfahren zur herstellung eines rekombinanten rinderadenovirus-vektors
ZA200602107B (en) Piroplasmid vaccine
BR112021026484A2 (pt) Polimerização de enzimas para reações de sequenciamento

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6O, 7O E 8O ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007.